AKT inhibitors represent a promising class of targeted therapies designed to interrupt the AKT (protein kinase B) signaling pathway, which plays a critical role in various cancer types and other diseases. These drugs are designed to combat the aberrant activation of AKT, a protein that is involved in crucial cellular processes such as metabolism, growth, and survival. The development and market...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian